Stock Earnings

Question 1

Syndax Pharmaceuticals Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Syndax Pharmaceuticals Inc의 총 자산은 $724이며, 순loss입니다.

Question 2

SNDX의 주요 재무 비율은 무엇인가요?

Accepted Answer

Syndax Pharmaceuticals Inc의 유동비율은 1.66이고, 순이익률은 -1,382.6, 주당 매출은 $0.26입니다.

Question 3

Syndax Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Syndax Pharmaceuticals Inc largest revenue segment is Syndax Pharmaceuticals, at a revenue of 23,680,000 in the most earnings release.For geography, United States is the primary market for Syndax Pharmaceuticals Inc, at a revenue of 23,680,000.

Question 4

Syndax Pharmaceuticals Inc은 수익성이 있나요?

Accepted Answer

no, 최신 재무제표에 따르면 Syndax Pharmaceuticals Inc의 순loss은 $-318입니다.

Question 5

Syndax Pharmaceuticals Inc에 부채가 있나요?

Accepted Answer

yes, Syndax Pharmaceuticals Inc의 부채는 436입니다.

Question 6

Syndax Pharmaceuticals Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Syndax Pharmaceuticals Inc의 총 발행 주식은 85.69주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	111	23	0	0	139	1
Revenue Growth (YoY)	594%	--	--	-100%	13,800%	0%
Cost of Revenue	5	0	--	--	--	--
Gross Profit	106	22	--	--	--	--
Selling, General & Admin	167	120	66	33	25	22
Research & Development	245	241	163	118	88	50
Operating Expenses	413	362	229	151	113	72
Other Non Operating Income (Expenses)	-1	0	0	0	0	0
Pretax Income	-311	-318	-209	-149	24	-73
Income Tax Expense	--	--	--	--	--	--
Net Income	-311	-318	-209	-149	24	-77
Net Income Growth	5%	52%	40%	-721%	-131%	38%
Shares Outstanding (Diluted)	86.62	85.62	70.37	60.8	53.6	41.3
Shares Change (YoY)	2%	22%	16%	13%	30%	35%
EPS (Diluted)	-3.6	-3.72	-2.97	-2.46	0.46	-1.87
EPS Growth	3%	25%	21%	-635%	-125%	2%
Free Cash Flow	-310	-274	-160	-133	29	-71
Free Cash Flow Per Share	-3.57	-3.2	-2.27	-2.18	0.54	-1.71
Gross Margin	95.49%	95.65%	--	--	--	--
Operating Margin	-275.67%	-1,473.91%	0%	0%	18.7%	-7,100%
Profit Margin	-280.18%	-1,382.6%	0%	0%	17.26%	-7,700%
Free Cash Flow Margin	-279.27%	-1,191.3%	0%	0%	20.86%	-7,100%
EBITDA	-306	-339	-229	-151	26	-71
EBITDA Margin	-275.67%	-1,473.91%	0%	0%	18.7%	-7,100%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-306	-339	-229	-151	26	-71
EBIT Margin	-275.67%	-1,473.91%	0%	0%	18.7%	-7,100%
Effective Tax Rate	--	--	--	--	--	--

Syndax Pharmaceuticals Inc (SNDX) Price

SNDX Stock Price Chart

SNDX Income

Follow-Up Questions